PROGENICS PHARMACEUTICALS IN

CUSIP: 743187106 Class: CMN

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2015
Shares 10,100 Value ($000) $62 Avg Close — Range —
Q4 2014
Shares 24,300 Value ($000) $184 Avg Close — Range —